Urease-powered nanobots significantly enhanced the efficacy of radionuclide therapy in bladder cancer treatment, showing superior tumor accumulation and penetration. This novel approach promises transformative advancements in managing non-muscle-invasive bladder cancer, as detailed in a recent study. Urease-powered nanobots significantly enhanced the efficacy of radionuclide therapy in bladder cancer treatment, showing superior tumor accumulation and penetration. This novel approach promises transformative advancements in managing non-muscle-invasive bladder cancer, as detailed in a recent study.